Gut Microbiota

The potential applications of traditional Chinese medicine in Parkinson’s disease: A new opportunity

Parkinson’s disease (PD) presents a common challenge for people all over the world and has become a major research hotspot due to the large population affected by the illness and the difficulty of clinical treatment. The prevalence of PD is increasing every year, the pathogenesis is complex, and the current treatment is ineffective. Therefore, it has […]

The potential applications of traditional Chinese medicine in Parkinson’s disease: A new opportunity Read More »

The influence of gut microbiota alteration on age-related neuroinflammation and cognitive decline

Recent emerging research on intestinal microbiota and its contribution to the central nervous system during health and disease has attracted significant attention. Age-related intestinal microbiota changes initiate brain aging and age-related neurodegenerative disorders. Aging is one of the critical predisposing risk factors for the development of neurodegenerative diseases. Maintaining a healthy gut microbiota is essential

The influence of gut microbiota alteration on age-related neuroinflammation and cognitive decline Read More »

Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases

The global prevalence of Alzheimer’s disease and Parkinson’s disease is steadily increasing due to the aging population. The lack of effective drugs against these neurodegenerative disorders makes it imperative to identify new strategies for their prevention and treatment. Recent studies have revealed that harnessing the power of the gut microbiota through modification of diet may

Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases Read More »

Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson’s disease

Parkinson’s disease (PD) is a multifocal degenerative disorder for which there is no cure. The majority of cases are sporadic with unknown etiology. Recent data indicate that untreated patients with de novo PD have increased colonic permeability and that both de novo and premotor patients have pathological expression of α-synuclein (α-syn) in their colon. Both

Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson’s disease Read More »

The Role of Gut Microbiome and Dysbiosis in Common Psychological,
Neurological, and Behavioral Disorders

According to psychobiotic research expansion, the gut microbiome—a colony of more than 1000 species—is connected to brainhealth and state of mind. Historically, even though a variety of body parts and systems were linked to the nervous system in thenineteenth century, researchers began began researching the gut, especially the stomach, calling it ‘the great abdominal brain’,

The Role of Gut Microbiome and Dysbiosis in Common Psychological,
Neurological, and Behavioral Disorders
Read More »

Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases

The global prevalence of Alzheimer’s disease and Parkinson’s disease is steadily increasing due to the aging population. The lack of effective drugs against these neurodegenerative disorders makes it imperative to identify new strategies for their prevention and treatment. Recent studies have revealed that harnessing the power of the gut microbiota through modification of diet may

Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases Read More »

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience

There has been a renewed interest in the potential use of psychedelics for the treatment of psychiatric conditions. Nevertheless, little is known about the mechanism of action and molecular pathways influenced by ayahuasca use in humans. Therefore, for the first time, our study aims to investigate the human metabolomics signature after consumption of a psychedelic, ayahuasca, and its connection

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience Read More »

Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management

Growing evidence suggests an increasing significance for the extent of gastrointestinal tract (GIT) dysfunction in Parkinson’s disease (PD). Most patients suffer from GIT symptoms, including dysphagia, sialorrhea, bloating, nausea, vomiting, gastroparesis, and constipation during the disease course. The underlying pathomechanisms of this α-synucleinopathy play an important role in disease development and progression, i.e., early accumulation

Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management Read More »

Food as Treatment of Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD), namely, Crohn’s disease (CD) and ulcerative colitis (UC), are lifelong and incurable chronic inflammatory diseases affecting6.8 million people worldwide. By 2030, the prevalence of IBD is estimated to reach 1%of the population in Western countries, and thus there is an urgent need to developeffective therapies to reduce the burden of this

Food as Treatment of Inflammatory Bowel Diseases Read More »

Metagenomic and Functional Characterization of Two Chilean
Kefir Beverages Reveals a Dairy Beverage Containing Active
Enzymes, Short-Chain Fatty Acids, Microbial β-Amyloids,
and Bio-Film Inhibitors

: Kefir beverage is a probiotic food associated with health benefits, containing probioticmicroorganisms and biomolecules produced during fermentation. The microbial compositionof these beverages varies among countries, geographical regions, and the substrates, therefore,the characterization of kefir beverages is of great relevance in understanding their potential healthpromoting and biotechnological applications. Therefore, this study presents the metagenomic andfunctional

Metagenomic and Functional Characterization of Two Chilean
Kefir Beverages Reveals a Dairy Beverage Containing Active
Enzymes, Short-Chain Fatty Acids, Microbial β-Amyloids,
and Bio-Film Inhibitors
Read More »